164 related articles for article (PubMed ID: 7556522)
1. Separation of graft-vs.-host disease and graft-vs.-leukemia effect against chronic myelogenous leukemia.
Champlin R
Exp Hematol; 1995 Oct; 23(11):1148-51. PubMed ID: 7556522
[No Abstract] [Full Text] [Related]
2. Acute severe form of lichenoid graft-versus-host disease after donor lymphocyte infusions.
Ruiz-Genao DP; F-Peñas P; Daudén E; García-F-Villalta MJ; Fraga J; García-Diez A
J Eur Acad Dermatol Venereol; 2006 May; 20(5):632-4. PubMed ID: 16684312
[No Abstract] [Full Text] [Related]
3. Molecular remission induced by fractionated dose-escalating donor leukocyte infusion without graft-versus-host disease in a patient with chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation.
Inai K; Wano Y; Yamamoto S; Ikebata Y; Iwasaki H; Tsutani H; Naiki H; Ueda T
Anticancer Res; 1999; 19(6C):5631-4. PubMed ID: 10697631
[TBL] [Abstract][Full Text] [Related]
4. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
[TBL] [Abstract][Full Text] [Related]
5. [Transplantation of the bone marrow to patients with chronic granulocytic leukemia].
Zduńczyk A
Wiad Lek; 1988 Dec; 41(24):1652-7. PubMed ID: 3076730
[No Abstract] [Full Text] [Related]
6. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
7. Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.
Champlin R; Jansen J; Ho W; Gajewski J; Nimer S; Lee K; Territo M; Winston D; Tricot G; Reichert T
Transplant Proc; 1991 Feb; 23(1 Pt 2):1695-6. PubMed ID: 1899162
[No Abstract] [Full Text] [Related]
8. Bone marrow transplantation from unrelated donors in chronic myelogenous leukemia.
Ehninger G; Klingebiel T; Schuler U; Einsele H; Schmidt H; Weiss B; Müller CA; Goldmann SF; Grosse-Wilde H; Niethammer D
Semin Hematol; 1993 Jul; 30(3 Suppl 3):49-50. PubMed ID: 8235708
[No Abstract] [Full Text] [Related]
9. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran.
Ghavamzadeh A; Iravani M; Jabehdar-Maralani P; Hajrasouliha A; Tavakoli S
Haematologica; 2003 Apr; 88(4):ELT13. PubMed ID: 12681990
[No Abstract] [Full Text] [Related]
11. Resolution of atopic dermatitis following allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Koharazawa H; Kanamori H; Takabayashi M; Yamaji S; Taguchi J; Fujimaki K; Ishigatsubo Y
Bone Marrow Transplant; 2005 Jun; 35(12):1223-4. PubMed ID: 15880131
[No Abstract] [Full Text] [Related]
12. Preferential usage of T cell receptor (TCR) V beta by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host disease.
Jiang YZ; Mavroudis DA; Dermime S; Molldrem J; Hensel NF; Barrett AJ
Bone Marrow Transplant; 1997 May; 19(9):899-903. PubMed ID: 9156263
[TBL] [Abstract][Full Text] [Related]
13. Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion.
Porter D; Levine JE
Semin Hematol; 2006 Jan; 43(1):53-61. PubMed ID: 16412789
[TBL] [Abstract][Full Text] [Related]
14. Use of an anti-interleukine 2 receptor monoclonal antibody for GvHD prophylaxis in unrelated bone marrow transplantation. GEGMO Group.
Belanger C
Bone Marrow Transplant; 1993; 11 Suppl 1():112-3. PubMed ID: 8448532
[No Abstract] [Full Text] [Related]
15. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
[TBL] [Abstract][Full Text] [Related]
16. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse.
Ustün C; Arslan O; Beksaç M; Koç H; Gürman G; Ozçelik T; Yilmaz B; Ilhan O; Akan H; Ozcan M; Demirer T; Uysal A; Konuk N; Arat M; Dilek I; Celebi H; Coskun HS
Biol Blood Marrow Transplant; 1999; 5(1):28-35. PubMed ID: 10232738
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
Gratwohl A; Hermans J; Niederwieser D; Frassoni F; Arcese W; Gahrton G; Bandini G; Carreras E; Vernant JP; Bosi A
Bone Marrow Transplant; 1993 Nov; 12(5):509-16. PubMed ID: 8298562
[TBL] [Abstract][Full Text] [Related]
18. A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts.
Henslee PJ; Byers VS; Jennings CD; Marciniak E; Thompson JS; Macdonald JS; Romond EH; Messino MJ; Scannon PJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):3004-7. PubMed ID: 2650413
[No Abstract] [Full Text] [Related]
19. [Leukocyte transfusion as therapy of recurrent CML after allogenic bone marrow transplantation].
Wiesneth M; Hertenstein B; Bunjes D; Novotny J; Stefanic M; Heinze B; Schreiner T; Kubanek B; Heimpel H; Arnold R
Beitr Infusionsther Transfusionsmed; 1994; 32():276-80. PubMed ID: 9480108
[TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results.
Miyamura K; Barrett AJ; Kodera Y; Saito H
Bone Marrow Transplant; 1994 Aug; 14(2):201-9. PubMed ID: 7994233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
